FDA Inspection 921522 — Sheffield Pharmaceuticals, LLC

Sheffield Pharmaceuticals, LLC — FEI 1210513

The FDA completed an inspection of Sheffield Pharmaceuticals, LLC on Mar 19, 2015 in New London, CT. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 8 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Mar 19, 2015
Fiscal Year
2015
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
New London, CT (United States)

Citations

IDCFRDescription
111221 CFR 211.25(a)Training--operations, GMPs, written procedures
135821 CFR 211.100(b)SOPs not followed / documented
136121 CFR 211.100(a)Absence of Written Procedures
180221 CFR 211.84(b)Representative Samples
202821 CFR 211.192Extent of discrepancy, failure investigations
369021 CFR 820.100(a)(3)Identification of actions needed
431421 CFR 211.84(d)(2)Reports of Analysis (Components)
439121 CFR 211.180(e)(2)Items to cover on annual reviews

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.